Page last updated: 2024-10-24

bupivacaine and Bisphosphonate Osteonecrosis

bupivacaine has been researched along with Bisphosphonate Osteonecrosis in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research Excerpts

ExcerptRelevanceReference
"The numb chin syndrome is a rare manifestation of intractable pain in the palliative care setting and represents a major therapeutic challenge."1.43Spontaneous Osteonecrosis of the Jaw During Bisphosphonate Therapy: An Unusual Etiology of the Numb Chin Syndrome. ( Bardelli, D; Fusi-Schmidhauser, T, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fusi-Schmidhauser, T1
Bardelli, D1

Other Studies

1 other study available for bupivacaine and Bisphosphonate Osteonecrosis

ArticleYear
Spontaneous Osteonecrosis of the Jaw During Bisphosphonate Therapy: An Unusual Etiology of the Numb Chin Syndrome.
    Journal of pain & palliative care pharmacotherapy, 2016, Volume: 30, Issue:3

    Topics: Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bupivaca

2016